샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777573

세계의 표본 수집 카드 시장

Specimen Collection Cards
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 392 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 표본 수집 카드 시장은 2030년까지 5억 5,970만 달러에 달할 전망

2024년에 4억 5,080만 달러로 추정되는 세계의 표본 수집 카드 시장은 2024-2030년의 분석 기간에 CAGR 3.7%로 성장하며, 2030년에는 5억 5,970만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 혈액은 CAGR 3.7%를 기록하며, 분석 기간 종료시에는 2억 2,110만 달러에 달할 것으로 예측됩니다. 타액 부문의 성장률은 분석 기간 중 CAGR 2.9%로 추정됩니다.

미국 시장은 1억 2,280만 달러로 추정, 중국은 CAGR 6.8%로 성장 예측

미국의 표본 수집 카드 시장은 2024년에 1억 2,280만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 6.8%로 2030년까지 1억 1,230만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.5%와 2.8%로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

세계의 표본 수집 카드 시장 - 주요 동향과 촉진요인 정리

현대 진단에서 표본 수집 카드가 점점 더 중요해지는 이유는 무엇인가?

표본 수집 카드는 주로 생물학적 샘플의 수집, 보관 및 운송을 단순화하는 능력으로 인해 현대 의료 진단, 공중 보건 모니터링 및 생물 의학 연구에 필수적인 툴이 되었습니다. 이 카드는 건조혈흔(DBS), 타액, 협측 세포 및 기타 생물학적 액체를 처리된 종이 또는 멤브레인에 수집 및 저장하도록 설계되었으며, 특히 원격지 및 자원이 제한된 환경에서 저침습적, 저비용, 논리적으로 효율적인 시료 채취 솔루션을 제공합니다. 제공합니다. 전 세계 의료 시스템이 분산화와 예방 의료에 점점 더 중점을 두는 가운데, 표본 수집 카드의 사용은 신생아 검진, 감염 모니터링, 유전자 검사, 법의학 분석, 맞춤형 의료 등의 용도로 확대되고 있습니다. 상온에서의 안정성으로 인해 콜드체인 물류가 불필요해져 복잡성과 비용을 모두 절감할 수 있습니다. 또한 팬데믹 시대에 우편 검사와 자택 검체 채취가 강조되면서 확장 가능한 진단 및 바이오 감시 전략의 일환으로 검체 수집 카드가 각광을 받게 되었습니다. 임상시험, 현장 기반 역학, 원격의료 환경 등 다양한 분야에서 이 카드는 보다 접근하기 쉽고 강력한 건강 모니터링 프레임워크로의 전환을 지원하고 있습니다.

카드 디자인 및 시료 안정성의 혁신은 어떻게 시장 도입을 촉진하고 있는가?

여과지 처리, 분석물 안정화, 다중 시료 통합의 기술 발전은 시료 수집 카드의 기능을 혁신적으로 변화시키고 있습니다. 제조업체들은 현재 핵산(DNA, RNA)과 단백질을 보다 효과적으로 보존하고, 보존 기간을 연장하며, 다양한 환경 조건에서 분석물의 무결성을 향상시키는 강화된 화학적 코팅이 적용된 카드를 생산하고 있습니다. 용량 확인용 지시약이 내장된 카드도 있으며, 가정 검사나 현장 환경에서 사용자가 충분히 일관된 샘플을 채취할 수 있도록 보장합니다. 다른 혁신 기술로는 다양한 시료 유형에 대응하는 다중 구역 수집 영역, 추적성을 위한 통합 바코드, 법의학 및 임상적 사용을 위한 규제 준수에 부합하는 변조 방지 포장 등이 있습니다. 가장 널리 사용되는 건조 혈액 스팟 카드는 PCR, 질량분석, ELISA, 차세대 염기서열 분석(NGS) 등의 다운스트림 용도에 최적화되어 고감도 진단 워크플로우에 적합합니다. 또한 검사실에서의 처리를 간소화하기 위해 자동화 대응 포맷도 개발되고 있습니다. 이러한 제품 수준의 개선으로 검체 수집 카드는 더욱 다용도하고, 사용자 친화적이며, 전 세계 진단약 공급망과의 호환성이 높아졌습니다.

수요가 가장 많이 증가하는 곳은 어디이며, 어떤 이용 사례가 성장을 주도하고 있는가?

검체 채취 카드에 대한 수요는 임상, 연구, 공중보건 분야에서 빠르게 증가하고 있으며, 특히 신생아 검진, 감염 진단, 유전자 검사 등의 분야에서 큰 성장세를 보이고 있습니다. 신생아 선별검사 프로그램은 특히 북미, 유럽 및 아시아태평양 일부에서 대사이상 및 유전적 이상에 대한 검사를 일상적으로 시행하고 있는 신생아 선별검사 프로그램 중 건혈증 스팟 카드의 가장 큰 사용자로 자리매김하고 있습니다. HIV, 간염, 결핵 조기 발견 프로그램의 전 세계 확대도 기존의 채혈이나 냉장 샘플 운송이 제한적인 개발도상국에서의 카드 사용을 촉진하고 있습니다. 소비자 직접 의뢰(DTC) 유전자 검사 회사들은 점점 더 많은 가정용 채혈 카드를 키트에 통합하고 있으며, 고객은 가계, 경력 검사, 건강 보고서를 위해 타액이나 뺨 닦은 액체 샘플을 제출할 수 있습니다. 바이오뱅크와 종단적 코호트 연구는 검체 카드를 사용하여 대규모 집단에서 검체를 수집, 보관, 저장하는 비용 효율적인 방법으로 검체를 수집, 보관, 보존합니다. 약물유전체학, 법의학 독성학, 치료제물 모니터링과 같은 새로운 분야에서도 비침습적이고 확장 가능한 샘플링을 위해 이러한 툴을 채택하고 있습니다. 정부, NGO, 학계 연구자들은 특히 대량 샘플링과 감시를 신속하고 효율적으로 수행해야 하는 세계 보건 위기 이후, 총체적으로 수요에 기여하고 있습니다.

표본 수집 카드 시장의 장기적인 성장 원동력은?

표본 수집 카드 시장의 성장은 세계 보건 우선순위, 진단의 분산화, 기술 혁신, 규제 발전과 관련된 여러 가지 연동된 요인에 의해 주도되고 있습니다. 주요 촉진요인은 조기 진단, 발병 추적 및 개별 치료를 지원하는 확장 가능하고 비용 효율적인 샘플 수집 툴에 대한 요구가 증가하고 있다는 점입니다. 재택치료, 원격 환자 모니터링, 디지털 진단으로의 전환은 전통적인 의료 환경 이외의 검체 채취를 위한 기본 툴로서 검체 카드의 관련성을 더욱 확대시키고 있습니다. 유전자 검사, 임상 연구, 바이오뱅크에 대한 투자가 증가함에 따라 분석물의 무결성이 높고 다운스트림 분자 워크플로우와 호환되는 샘플을 저장할 수 있는 카드에 대한 장기적인 수요가 발생하고 있습니다. 이와 함께 공중보건기관은 검체 카드를 역학조사 및 백신 접종 모니터링에 통합하여 집단 건강관리에서 검체 카드의 역할을 강화하고 있습니다. 규제 당국이 건조 혈액 반점 및 대체 검체 카드가 임상 등급 데이터 소스로서 유효하다는 인식도 진단에서 검체 카드 사용을 정상화하는 데 도움이 되고 있습니다. 건강 형평성, 질병 예방, 신속한 대응 능력이 전 세계에서 주목받고 있는 가운데, 검체 채취 카드는 전 세계 어디에서나 환자와 검사실 간의 격차를 해소하는 중요한 원동력이 될 것입니다.

부문

검체(혈액, 타액, 뇨, 협세포, 기타), 소재(코튼 & 셀룰로오스 기반, 섬유 기반, 기타), 용도(신생아 스크리닝, 감염증 검사, 치료제 모니터링, 법의학, 조사, 웰빙/건강 모니터링, 기타 용도)

조사 대상 기업의 예

  • Ahlstrom-Munksjo
  • ARCHIMEDlife
  • Becton, Dickinson and Company(BD)
  • Capitainer AB
  • Cardinal Health
  • CENTOGENE N.V.
  • DBS System SA
  • Eastern Business Forms, Inc.(EBF)
  • EUROIMMUN AG
  • F. Hoffmann-La Roche Ltd
  • GenTegra LLC
  • Greiner Bio-One International GmbH
  • Hemaxis
  • Lipomic Healthcare
  • Medline Industries, LP
  • Mitra Microsampling Devices(Neoteryx)
  • Munktell Filter AB
  • Neoteryx LLC
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • QIAGEN N.V.
  • RDA Spot
  • SARSTEDT AG & Co. KG
  • Shimadzu Scientific Instruments
  • Sirchie Acquisition Company, LLC
  • Synergy Medical Systems LLP
  • Thomas Scientific
  • VWR International, LLC
  • Whatman(part of Cytiva)

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.05

Global Specimen Collection Cards Market to Reach US$559.7 Million by 2030

The global market for Specimen Collection Cards estimated at US$450.8 Million in the year 2024, is expected to reach US$559.7 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Blood, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$221.1 Million by the end of the analysis period. Growth in the Saliva segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$122.8 Million While China is Forecast to Grow at 6.8% CAGR

The Specimen Collection Cards market in the U.S. is estimated at US$122.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$112.3 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Specimen Collection Cards Market - Key Trends & Drivers Summarized

Why Are Specimen Collection Cards Gaining Critical Importance in Modern Diagnostics?

Specimen collection cards have become an essential tool in modern medical diagnostics, public health surveillance, and biomedical research, primarily due to their ability to simplify biological sample collection, preservation, and transportation. Designed to collect and store dried blood spots (DBS), saliva, buccal cells, or other biological fluids on treated paper or membranes, these cards offer a minimally invasive, low-cost, and logistically efficient solution for sample acquisition-especially in remote or resource-limited settings. With global healthcare systems increasingly focused on decentralization and preventive care, the use of specimen collection cards is expanding across applications such as newborn screening, infectious disease monitoring, genetic testing, forensic analysis, and even personalized medicine. Their stability at ambient temperatures eliminates the need for cold-chain logistics, reducing both complexity and cost. Moreover, the pandemic-era emphasis on mail-in testing and at-home sample collection has brought specimen collection cards into the spotlight as part of scalable diagnostics and bio-surveillance strategies. Whether in clinical trials, field-based epidemiology, or telehealth settings, these cards are supporting the global shift toward more accessible and resilient health monitoring frameworks.

How Are Innovations in Card Design and Sample Stability Enhancing Market Adoption?

Technological advancements in filter paper treatment, analyte stabilization, and multi-sample integration are transforming the capabilities of specimen collection cards. Manufacturers are now producing cards with enhanced chemical coatings that preserve nucleic acids (DNA, RNA) and proteins more effectively, extending shelf life and improving the integrity of analytes under varied environmental conditions. Some cards are embedded with indicator dyes for volume verification, ensuring sufficient and consistent sample collection by users in home-testing or field environments. Other innovations include multi-zone collection areas for different sample types, integrated barcoding for traceability, and tamper-evident packaging that meets regulatory compliance for forensic and clinical use. Dried blood spot cards, the most widely used format, are increasingly optimized for downstream applications such as PCR, mass spectrometry, ELISA, and next-generation sequencing (NGS), thereby aligning with high-sensitivity diagnostic workflows. Automation-compatible formats are also being developed to streamline laboratory processing. These product-level improvements are making specimen collection cards more versatile, user-friendly, and compatible with global diagnostic supply chains-key factors in enabling broader adoption in both high-throughput laboratories and point-of-care environments.

Where Is Demand Rising Fastest, and Which Use Cases Are Leading Growth?

Demand for specimen collection cards is rising rapidly across clinical, research, and public health sectors, with particularly strong growth in applications such as newborn screening, infectious disease diagnostics, and genetic testing. Newborn screening programs remain the largest and most established user of dried blood spot cards, especially in North America, Europe, and parts of Asia-Pacific, where testing for metabolic and genetic disorders is routine. The global expansion of early detection programs for HIV, hepatitis, and tuberculosis is also driving card usage in developing countries, where conventional phlebotomy and refrigerated sample transport may be limited. Direct-to-consumer (DTC) genetic testing companies are increasingly incorporating at-home collection cards into their kits, allowing customers to submit saliva or cheek swab samples for ancestry, carrier screening, or wellness reports. Biobanks and longitudinal cohort studies are using specimen cards to collect, store, and archive samples from large populations in a compact, cost-effective manner. Emerging areas like pharmacogenomics, forensic toxicology, and therapeutic drug monitoring are also adopting these tools for non-invasive, scalable sampling. Governments, NGOs, and academic researchers are collectively contributing to demand, particularly in the wake of global health crises where mass sampling and surveillance are needed quickly and efficiently.

What’s Driving the Long-term Growth of the Specimen Collection Cards Market?

The growth in the specimen collection cards market is driven by several interlinked factors tied to global health priorities, diagnostic decentralization, technological innovation, and regulatory evolution. A primary driver is the rising need for scalable, cost-effective sample collection tools that support early diagnosis, outbreak tracking, and personalized treatment-especially in low-resource or geographically dispersed populations. The shift toward home-based healthcare, remote patient monitoring, and digital diagnostics is further expanding the relevance of specimen cards as foundational tools for sample acquisition outside traditional healthcare settings. Increased investment in genetic testing, clinical research, and bio-banking is creating long-term demand for cards that can store samples with high analyte integrity and compatibility with downstream molecular workflows. In parallel, public health agencies are integrating specimen cards into epidemiological studies and vaccination monitoring, reinforcing their role in population health management. Regulatory recognition of dried blood spot and alternative specimen cards as valid sources for clinical-grade data is also helping to normalize their use in diagnostics. As global focus intensifies on health equity, disease prevention, and rapid response capabilities, specimen collection cards are set to remain a vital enabler-bridging the gap between patients and laboratories, wherever they are in the world.

SCOPE OF STUDY:

The report analyzes the Specimen Collection Cards market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Specimen (Blood, Saliva, Urine, Buccal Cells, Others); Material (Cotton & Cellulose-based, Fiber-based, Others); Application (New Born Screening, Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Ahlstrom-Munksjo
  • ARCHIMEDlife
  • Becton, Dickinson and Company (BD)
  • Capitainer AB
  • Cardinal Health
  • CENTOGENE N.V.
  • DBS System SA
  • Eastern Business Forms, Inc. (EBF)
  • EUROIMMUN AG
  • F. Hoffmann-La Roche Ltd
  • GenTegra LLC
  • Greiner Bio-One International GmbH
  • Hemaxis
  • Lipomic Healthcare
  • Medline Industries, LP
  • Mitra Microsampling Devices (Neoteryx)
  • Munktell Filter AB
  • Neoteryx LLC
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • QIAGEN N.V.
  • RDA Spot
  • SARSTEDT AG & Co. KG
  • Shimadzu Scientific Instruments
  • Sirchie Acquisition Company, LLC
  • Synergy Medical Systems LLP
  • Thomas Scientific
  • VWR International, LLC
  • Whatman (part of Cytiva)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Specimen Collection Cards - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Early Disease Detection Throws the Spotlight on Specimen Collection Cards as Critical Diagnostic Tools
    • Rising Demand for At-home and Remote Testing Spurs Growth in Dried Blood Spot (DBS) and Saliva-based Collection Card Use
    • Here's How Newborn Screening Programs Expand the Addressable Market for Standardized Specimen Collection Cards
    • Decentralized and Mobile Healthcare Models Strengthen the Business Case for Easy-to-use, Ambient-stable Collection Formats
    • Increased Use in Genomic and Biomarker-based Studies Propels Innovation in Multi-analyte-compatible Collection Cards
    • Here's the Story: Infectious Disease Surveillance and Pandemic Preparedness Initiatives Drive Public Sector Procurement
    • Integration with Telehealth and Mail-in Lab Testing Platforms Accelerates Adoption in Consumer-facing Diagnostics
    • Rising Demand for Sample Integrity and Traceability Fuels Growth of Barcoded and Pre-labeled Collection Cards
    • Here's How Advancements in Sample Preservation Technologies Enable Long-term Storage Without Cold Chain Requirements
    • Global Expansion of Biobanking and Population-scale Research Projects Generates Demand for High-quality Collection Cards
    • Point-of-care and Field Testing Applications Sustain Growth in Remote, Resource-limited, and Emergency Settings
    • Here's How Personalized Medicine and Direct-to-consumer Testing Trends Create Opportunities for Specialty Specimen Cards
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Specimen Collection Cards Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Specimen Collection Cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Saliva by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Buccal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Buccal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Buccal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Specimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Diseases Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Infectious Diseases Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Infectious Diseases Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Therapeutic Drug Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Wellbeing / Health Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Wellbeing / Health Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Wellbeing / Health Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for New Born Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for New Born Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for New Born Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Cotton & Cellulose-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Cotton & Cellulose-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Cotton & Cellulose-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Fiber-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Fiber-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Fiber-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • JAPAN
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • CHINA
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • EUROPE
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Specimen Collection Cards by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • FRANCE
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • GERMANY
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 140: Spain Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Spain Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Spain 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 149: Russia Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Russia Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Russia 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Specimen Collection Cards by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 179: Australia Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Australia Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Australia 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • INDIA
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 182: India Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 188: India Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: India Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: India 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 197: South Korea Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: South Korea Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: South Korea 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Asia-Pacific Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Specimen Collection Cards by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Latin America Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Latin America 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 227: Argentina Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Argentina Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Argentina 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 236: Brazil Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Brazil Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Brazil 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 245: Mexico Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Mexico Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Mexico 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Latin America Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Latin America 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Specimen Collection Cards by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Middle East Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Middle East 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 275: Iran Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Iran Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Iran 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 284: Israel Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Israel Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Israel 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Saudi Arabia Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Saudi Arabia 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 302: UAE Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: UAE Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: UAE 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Middle East Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Middle East 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
  • AFRICA
    • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
    • TABLE 320: Africa Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Africa Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Africa 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제